Advertisement

Related Videos

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Opportunities to Optimize Cancer Policies Panel Discussion

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Mar
13
Today In Oncology
Can Viral Respiratory Infections Increase Lung Cancer Risk
Female Reproductive Cancers Linked to Reduced Survival Advantage Over Males
Early Study Evaluates Two-Vaccine Strategy in T-Cell Lymphoma
Structured Exercise Plan for Patients With Cancer May Reduce Cognitive Effects of Chemotherapy
Risk of Breast Cancer After Ovarian Cancer in Women With BRCA1/2 Variants
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo